Express

Prenetics Sells Ownership of ACT Genomics for $71.78 Million, Plans to Strengthen Bitcoin Financial Strategy

Summary: According to reports, NASDAQ-listed company Prenetics has announced a final agreement to transfer its ownership in ACT Genomics Holdings Company Limited to Delta Electronics Co., Ltd. for approximately $71.78 million. The divestment of ACT Genomics significantly enhances Prenetics' financial foundation, with an estimated cash reserve of around $86 million and cash and short-term assets totaling ...

According to reports, NASDAQ-listed company Prenetics has announced a final agreement to transfer its ownership in ACT Genomics Holdings Company Limited to Delta Electronics Co., Ltd. for approximately $71.78 million. The divestment of ACT Genomics significantly enhances Prenetics' financial foundation, with an estimated cash reserve of around $86 million and cash and short-term assets totaling $117 million. The company maintains a debt-free balance sheet, allowing for exploration of other financial management solutions, including adoption of digital assets and a Bitcoin financial strategy.

Last Update:

Tags:
Link: Prenetics Sells Ownership of ACT Genomics for $71.78 Million, Plans to Strengthen Bitcoin Financial Strategy   [Copy]
  • The Road to 2026: Where Is the Web3 Ecosystem Heading Next? 13 days ago
  • Vishwa Advances Agentic Infrastructure Research Through Contribution to Emerging Framew... 29 days ago
  • BitMart US Launches Operations with 49-State Licensing and Zero-Fee Program November 17, 2025
  • Global Financial Giants Enter Stablecoin Arena in Pivotal Shift October 30, 2025
  • CRYPTO'S NEW PLAY: 24/7 STOCK TRADING October 29, 2025
  • You need to login to comment.